The chemical class designated as CBWD Activators encompasses a diverse array of compounds that share the common function of activating the CBWD protein. This activation can occur through various biochemical pathways and mechanisms, each unique to the nature of the activator involved. The primary mode of action for these activators includes altering intracellular ion concentrations, modulating signal transduction pathways, and affecting the regulation of gene expression or enzymatic activity. The activators can facilitate the function of CBWD by providing essential ions that serve as cofactors or by influencing the activity of GTPases, which are integral to various cellular processes. By altering the levels of secondary messengers such as cAMP, these compounds can initiate a cascade of cellular events leading to the activation of CBWD. Additionally, they can bind to specific enzyme inhibitors or antagonists to prevent the deactivation of CBWD, thereby sustaining its active state and ensuring the continuity of its physiological role.
CBWD Activators are characterized by their ability to engage with cellular signaling components and catalytic activities to promote the CBWD protein's function. This involves direct interactions with the protein itself or indirect effects on the cellular environment that result in an increased activity of CBWD. For instance, certain members of this chemical class can interact with membrane-bound receptors or ion channels to alter the cellular ionic balance, which in turn can have an activating effect on CBWD. Others can influence the phosphorylation state of proteins within the cell, thereby modifying CBWD activity. These activators can also affect the polymerization of cytoskeletal elements, which may be necessary for the full activation of CBWD. In essence, CBWD Activators operate through a network of finely tuned biochemical interactions, ensuring that CBWD is activated in a manner that is congruent with the cell's physiological demands.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Provides zinc ions, which may be required for the activation and proper function of Zng1. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese ions can act as cofactors for many enzymes and may affect zinc homeostasis and related proteins, which could activate CBWD. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
A calcium ionophore that increases intracellular calcium levels, which could modulate zinc levels and GTPase activity, potentially activating CBWD. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
A cAMP analog that activates protein kinase A (PKA) and may influence GTPase activating proteins, which could activate CBWD. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
A ROCK inhibitor that can affect the actin cytoskeleton and interplay with GTPase regulation, which could activate CBWD. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Inhibits Rac1 GTPase interaction with its GEFs, influencing pathways that CBWD could be a part of, potentially activating it. | ||||||
1-β-D-Arabinofuranosylcytosine | 147-94-4 | sc-201628 sc-201628A sc-201628B sc-201628C sc-201628D | 1 g 5 g 25 g 100 g 250 g | $150.00 $263.00 $518.00 $731.00 $1461.00 | 1 | |
A nucleoside analog that interferes with DNA synthesis and may affect cell cycle-related GTPases, which could activate CBWD. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
A MEK inhibitor which affects GTPase signaling pathways by inhibiting the MAPK/ERK pathway, potentially activating CBWD. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
A PI3K inhibitor that affects downstream signaling pathways involving GTPases, which could activate CBWD. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
A calmodulin antagonist that affects calcium-mediated signaling pathways and could influence GTPase activity, potentially activating CBWD. | ||||||